Does carrying excess weight raise cancer risk? What the big studies show

Carrying excess body weight is associated with a higher risk of many cancers — but the effect is strikingly specific. For some sites the association is strong; for others it is weak, absent, or even reversed. The tidy public-health line that "obesity causes cancer" is broadly right in aggregate and misleading in the particulars, and the two largest bodies of evidence make clear exactly which cancers the link is about.

The 5.24 million-person cohort

The most granular study followed 5.24 million UK adults through primary-care records, of whom 166,955 developed one of 22 cancers of interest [s1]. Higher body-mass index was associated with 17 of those 22 cancers, but the size of the association varied enormously by site [s1].

The strongest link by far was uterine cancer: each 5 kg/m² increase in BMI was associated with a hazard ratio of 1.62 (99% confidence interval 1.56 to 1.69) [s1]. Then came gallbladder cancer (1.31), kidney (1.25), cervix (1.10), thyroid (1.09) and leukaemia (1.09) [s1]. Some common cancers showed smaller positive associations that varied by underlying BMI or personal characteristics: liver (1.19), colon (1.10), ovarian (1.09) and postmenopausal breast cancer (1.05) [s1].

Not every association pointed the same way. The study estimated inverse associations with prostate cancer (0.98) and premenopausal breast cancer (0.89), including among people who had never smoked [s1]. For lung and oral-cavity cancer, there was no association in never-smokers, meaning the apparent protective effect overall was driven by smokers and ex-smokers — most likely residual confounding, because leaner people in that group were disproportionately smokers [s1].

What the numbers imply at population scale

Small per-person hazard ratios still matter across a whole country. Assuming the associations are causal, the study estimated that 41% of uterine cancers, and 10% or more of gallbladder, kidney, liver and colon cancers, could be attributable to excess weight [s1]. Projecting forward, the authors calculated that a population-wide rise of just 1 kg/m² in average BMI would produce roughly 3,790 additional UK patients each year developing one of the ten cancers positively linked to weight [s1].

That is the crux of why guidance treats body fatness as a major modifiable cancer risk factor despite modest individual hazard ratios: a small shift multiplied across tens of millions of people becomes a large number of cases.

The earlier meta-analysis that mapped the pattern

The UK cohort refined a picture drawn six years earlier by a systematic review and meta-analysis of prospective studies, which pooled 221 datasets covering 282,137 incident cancer cases across 20 cancer types [s2]. It too found that the association depended on both site and sex.

In men, each 5 kg/m² increase in BMI was strongly associated with oesophageal adenocarcinoma (relative risk 1.52), thyroid (1.33), colon (1.24) and renal cancer (1.24) [s2]. In women, the strongest associations were with endometrial cancer (1.59), gallbladder (1.59), oesophageal adenocarcinoma (1.51) and renal cancer (1.34) [s2]. Weaker positive associations — relative risks below 1.20 — were seen for postmenopausal breast, pancreatic and colon cancers in women, and for leukaemia, multiple myeloma and non-Hodgkin lymphoma in both sexes [s2]. The colon-cancer association was stronger in men than in women [s2].

How to read it honestly

Both studies are observational, and neither can prove that excess weight causes any individual cancer. They cannot fully separate body fat from the diet, activity, alcohol and social factors that travel with it, and the smoking-related reversals for lung and prostate cancer show how easily confounding can distort a single site's estimate [s1][s2]. The consistency of the findings across two very different methods — a mega-cohort and a pooled meta-analysis — is what makes the overall direction credible, not any one hazard ratio.

The practical, non-prescriptive takeaway is that the weight–cancer link is real but selective. It is powerful for endometrial and oesophageal-adenocarcinoma risk, moderate for kidney, gallbladder, liver and colon, weak or inconsistent for others, and does not apply uniformly across every cancer or every person [s1][s2]. This article is informational and is not medical advice; body weight is one of many factors that shape cancer risk, and none of these figures translates into a target for any individual.

Sources

• [s1] Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults — The Lancet, 30 August 2014. https://doi.org/10.1016/S0140-6736(14)60892-8
• [s2] Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies — The Lancet, 16 February 2008. https://doi.org/10.1016/S0140-6736(08)60269-X